Fractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas

机译：贝伐珠单抗加伊立替康治疗后的分级立体定向放疗加贝伐单抗作为高级神经胶质瘤的抢救方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimTo evaluate the possibility of implementing a new scheme of rescue treatment after relapse or progression of high-grade glioma (HGG) treated at the first-line with bevacizumab and irinotecan (BVZ+CPT11), evaluating the response and toxicity of associating BVZ and fractionated stereotactic radiotherapy (BVZ+FSRT).

机译：目的评估一线用贝伐单抗和伊立替康（BVZ + CPT11）治疗的高级别神经胶质瘤（HGG）复发或进展后实施新的抢救治疗方案的可能性，评估联合BVZ和分级分离的反应和毒性立体定向放射治疗（BVZ + FSRT）。

著录项

期刊名称 Reports of Practical Oncology and Radiotherapy
作者
Antonio José Conde-Moreno; Raquel García-Gómez; María Albert-Antequera; Piedad Almendros-Blanco; Ramón De Las Peñas-Bataller; Verónica González-Vidal; José Luis López-Torrecilla; Carlos Ferrer-Albiach;
展开▼
作者单位

展开▼
年(卷),期 2015(20),3
年度 2015
页码 231–238
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
High-grade glioma Rescue treatment Bevacizumab Fractionated stereotactic radiotherapy;

机译：高度神经胶质瘤;抢救治疗;贝伐单抗;分级立体定向放射治疗;

相似文献

外文文献
中文文献
专利

1. Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas [J] . Takayuki Yasuda, Yoshihiro Muragaki, Masayuki Nitta, World neurosurgery . 2018,第期

机译：立体定向放射治疗和贝伐单抗的有效性及复发性高等胶质瘤：脱氢脱酶野生型经常性高等胶质瘤的潜在疗法
2. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. [J] . Zuniga RM, Torcuator R, Jain R, Journal of neuro-oncology. . 2009,第3期

机译：贝伐单抗联合伊立替康治疗复发性高级别神经胶质瘤患者的疗效，安全性，反应和复发模式。
3. Salvage Fractionated Stereotactic Re-irradiation (FSRT) for Patients with Recurrent High Grade Gliomas Progressed after Bevacizumab Treatment [J] . Shi Wenyin, Blomain Erik S, Siglin Joshua, JHN Journal . 2018,第1期

机译：贝伐单抗治疗后复发性高级别胶质瘤患者抢救分次立体定向放射治疗（FSRT）
4. Prediction of Glioblastoma Multiforme Response to Bevacizumab Treatment Using Diffusion and Perfusion Imaging [C] . Ehsan Abadi, Hamid Soltanian-Zadeh, Lisa Scarpace, Iranian Conference on Biomedical Engineering . 2015

机译：利用扩散和灌注成像预测胶质母细胞瘤对贝伐单抗治疗的响应
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. RT-31SURVIVAL OUTCOMES IN PATIENTS RECEIVING BOTH FRACTIONATED STEREOTACTIC RADIOTHERAPY AND BEVACIZUMAB FOR RECURRENT HIGH GRADE GLIOMA [O] . Joshua Siglin, Joshua Palmer, Colin Champ, 2014

机译：RT-31复发性高剂量胶质瘤患者接受分形立体定向放射治疗和贝伐珠单抗治疗的生存结果
7. Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment [O] . Wenyin Shi, Erik S. Blomain, Joshua Siglin, 2018

机译：纠正：抗复制高级胶质瘤患者的持续分级立体定向再辐射（FSRT）进行蜂产物治疗后进展

Fractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas

摘要

著录项

相似文献

相关主题

期刊订阅